Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 17, 2026, 18:12 UTC
  • 3
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001193125-26-161786 <b>Size:</b> 315 KB

Comment Full text

MORGAN STANLEY (MS)

  • SEC News
  • April 17, 2026, 18:11 UTC
  • 3
  • 0 comments

New Form FWP - MORGAN STANLEY <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001839882-26-020508 <b>Size:</b> 61 KB

Comment Full text

BANK OF AMERICA CORP /DE/ (BAC)

  • SEC News
  • April 17, 2026, 18:11 UTC
  • 3
  • 0 comments

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001918704-26-010204 <b>Size:</b> 421 KB

Comment Full text

XMAX INC. (XWIN)

  • SEC News
  • April 17, 2026, 18:11 UTC
  • 3
  • 0 comments

New Form DEF 14A - XMax Inc. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001493152-26-017915 <b>Size:</b> 3 MB

Comment Full text

VERA BRADLEY, INC. (VRA)

  • SEC News
  • April 17, 2026, 18:11 UTC
  • 3
  • 0 comments

New Form 8-A12B/A - Vera Bradley, Inc. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001628280-26-025859 <b>Size:</b> 25 KB

Comment Full text

MARVELL TECHNOLOGY, INC. (MRVL)

  • SEC News
  • April 17, 2026, 18:11 UTC
  • 3
  • 1 comments

Koopmans Chris 🟡 adjusted position in 43.5K shares (5 derivative) of Marvell Technology, Inc. (MRVL) at $134.60 ($11.3M) Transaction Date: Apr 15, 2026 | Filing ID: 025671

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 17, 2026, 18:10 UTC
  • 3
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001193125-26-161783 <b>Size:</b> 1 MB

Comment Full text

WM TECHNOLOGY, INC. (MAPSW)

  • SEC News
  • April 17, 2026, 18:09 UTC
  • 3
  • 0 comments

New Form 25 - WM TECHNOLOGY, INC. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001104659-26-044966 <b>Size:</b> 11 KB

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 17, 2026, 18:08 UTC
  • 3
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001193125-26-161781 <b>Size:</b> 553 KB

Comment Full text

CEL SCI CORP (CVM)

  • SEC News
  • April 17, 2026, 18:08 UTC
  • 3
  • 0 comments

New Form S-1 - CEL SCI CORP <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001654954-26-003679 <b>Size:</b> 1 MB

Comment Full text
  • Previous
  • 826
  • 827
  • 828
  • 829
  • 830
  • Next

Search

News categories

  • Technical Exchange News(12074)
  • Event(5328)
  • SEC News(250961)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150288)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin